# Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

> **NCT00659919** · PHASE4 · COMPLETED · sponsor: **BeerYaakov Mental Health Center** · enrollment: 13 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Trazodone

## Key facts

- **NCT ID:** NCT00659919
- **Lead sponsor:** BeerYaakov Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659919, "Treatment of Neuroleptic Induced Acute Akathisia With Trazodone". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00659919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*